We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-8.2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$462M
AUM Growth
-$51.6M
Cap. Flow
-$441K
Cap. Flow %
-0.1%
Top 10 Hldgs %
15.6%
Holding
395
New
18
Increased
8
Reduced
14
Closed
13

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.31M
2
ABBV icon
AbbVie
ABBV
+$1.95M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$1.27M
4
GERN icon
Geron
GERN
+$1.18M
5
KHC icon
Kraft Heinz
KHC
+$1.16M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.93M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$1.86M
3
AEC
ASSOCIATED ESTATES REALTY CORP
AEC
+$1.72M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.3M
5
PLL
PALL CORP
PLL
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 14.94%
3 Healthcare 14.92%
4 Industrials 11.55%
5 Consumer Staples 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNPR
301
DELISTED
Juniper Networks
JNPR
$386K 0.08%
15,000
– –
HAYN
302
DELISTED
Haynes International, Inc.
HAYN
$378K 0.08%
10,000
– –
LM
303
DELISTED
Legg Mason, Inc.
LM
$374K 0.08%
9,000
– –
OA
304
DELISTED
Orbital ATK, Inc.
OA
$374K 0.08%
5,209
– –
ELDN icon
305
Eledon Pharmaceuticals
ELDN
$261M
$362K 0.08%
+216
New +$445K
HII icon
306
Huntington Ingalls Industries
HII
$12.9B
$357K 0.08%
3,333
– –
KEYS icon
307
Keysight
KEYS
$54.5B
$356K 0.08%
11,542
– –
SPLS
308
DELISTED
Staples Inc
SPLS
$356K 0.08%
30,348
– –
ARQL
309
DELISTED
Arqule Inc
ARQL
$355K 0.08%
190,000
– –
HALO icon
310
Halozyme
HALO
$9.79B
$336K 0.07%
+25,000
New +$502K
NRG icon
311
NRG Energy
NRG
$28.3B
$334K 0.07%
22,496
– –
NKTR icon
312
Nektar Therapeutics
NKTR
$2.39B
$329K 0.07%
2,000
– –
BDBD
313
DELISTED
BOULDER BRANDS INC
BDBD
$328K 0.07%
40,000
– –
KYNB
314
Kyntra Bio
KYNB
$27.2M
$315K 0.07%
+574
New +$348K
AIG icon
315
American International
AIG
$41.7B
$313K 0.07%
5,500
– –
MRO
316
DELISTED
Marathon Oil Corporation
MRO
$308K 0.07%
20,000
– –
EXC icon
317
Exelon
EXC
$47.2B
$303K 0.07%
14,300
– –
XRAY icon
318
Dentsply Sirona
XRAY
$2.68B
$303K 0.07%
6,000
– –
GT icon
319
Goodyear
GT
$2B
$293K 0.06%
10,000
– –
VWTR
320
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$290K 0.06%
30,000
– –
AAL icon
321
American Airlines Group
AAL
$10.1B
$289K 0.06%
7,439
– –
DOV icon
322
Dover
DOV
$27.6B
$286K 0.06%
6,190
– –
ACHN
323
DELISTED
Achillion Pharmaceuticals
ACHN
$276K 0.06%
+40,000
New +$326K
ARRY
324
DELISTED
Array Biopharma Inc
ARRY
$274K 0.06%
60,000
– –
KSU
325
DELISTED
Kansas City Southern
KSU
$273K 0.06%
3,000
– –
11 12
13
14 15

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2015 Portfolio in Review

As of Q3 2015, NJ State Employees Deferred Compensation Plan held 395 positions worth $462M, down 10% from $514M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2015 filing shows 18 new, 8 increased, 14 reduced and 13 closed positions. Its largest new stake was Biogen: 7,000 shares worth $2.04M. The largest sale was Johnson & Johnson, an estimated $1.93M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2015 buy was Biogen: 7,000 shares worth $2.04M.
  • NJ State Employees Deferred Compensation Plan added most to AbbVie in Q3 2015, an estimated $1.95M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.93M.
  • NJ State Employees Deferred Compensation Plan fully exited ASSOCIATED ESTATES REALTY CORP in Q3 2015, selling an estimated $1.72M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $462M portfolio in Q3 2015.
  • NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 13 in Q3 2015.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 10% quarter-over-quarter to $462M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.